NeXT Dx™ Test Gene List

Cancer Genes of Clinical Importance

Single nucleotide variants, small insertions and deletions, copy number alterations, and gene fusions involving the genes in the NeXT Dx Test Gene List may be reported in the test. Genes for which copy number alteration is assessed are indicated by an asterisk (“*”). Genes in BOLD are those for which FDA approved drugs are available to treat solid tumors as of August 2020 (FDA, oncoKB data).